• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·6078.T
Share

Value HR Co.,Ltd. Stocks

¥ 1513Last Updated 24.07.2026

Issuer Rating

3/7
Performance

Modest

Risk

Moderate

Recommendation

Sell

Market Cap

¥ 249.18M

¥ 1513
Key Takeaways

Risk factor

Poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in Tokyo, Japan, in 2001, Value HR Co.,Ltd. specializes in providing a wide array of healthcare services. The company is primarily involved in the conceptualization, development, operation, and administration of its Value Cafeteria welfare support system. For businesses, Value HR offers consultancy on establishing health insurance associations, industrial health services, welfare programs, and acts as an agent for medical checkups. Additionally, it supports health insurance societies and health checkup facilities with administrative outsourcing, temporary staffing solutions, health management and data analytics assistance, probate services, and electronic application system implementation. The company further provides bespoke systems, including a web-based metabo countermeasure support system, a stress check system, and a medical expense itemization notification system.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.07.2026 21:54

A Wake-Up Call That Could Transform the AI Market: What to Look for in Hyperscalers’ Reports

24.07.2026 21:23

Brent crude fell 5%. Reuters reported on an attempt to resume negotiations between the U.S. and Iran

24.07.2026 19:30

Jewelry sales in Japan have reached a record high. Which companies are benefiting from this?

24.07.2026 19:05

How to Stay Optimistic When AI Surpasses Humans: Key Takeaways from Elon Musk's Interview

24.07.2026 18:42

The U.S. denied British fintech company Wise a banking license

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026